VeriMomp-cresyl isovalerate est-il sûr pendant la grossesse ?
No EU Annex II/III listing or harmonised CLP reproductive classification found; no SCCS or CIR safety opinion specifically for p‑cresyl isovalerate. JECFA evaluated p‑cresyl isovalerate (p‑tolyl isovalerate) as a flavouring and concluded 'no safety concern at current levels of intake' (2000). ECHA substance record shows REACH registration but no harmonised reproductive hazard classification; supplier SDSs report acute oral hazard statements (H302) but not H360/H361. Given the absence of reproductive or developmental toxicity evidence, hazard (h) and mechanism (m) are scored 0; dermal absorption from a small lipophilic ester used as a fragrance is likely low but measurable, so exposure (e) = 1. Sources: ECHA substance record, JECFA, PubChem/supplier pages, EWG listing.
Related ingredients
Frequently asked questions
- p-cresyl isovalerate est-il sûr pendant la grossesse ?
- No EU Annex II/III listing or harmonised CLP reproductive classification found; no SCCS or CIR safety opinion specifically for p‑cresyl isovalerate. JECFA evaluated p‑cresyl isovalerate (p‑tolyl isovalerate) as a flavouring and concluded 'no safety concern at current levels of intake' (2000). ECHA substance record shows REACH registration but no harmonised reproductive hazard classification; supplier SDSs report acute oral hazard statements (H302) but not H360/H361. Given the absence of reproductive or developmental toxicity evidence, hazard (h) and mechanism (m) are scored 0; dermal absorption from a small lipophilic ester used as a fragrance is likely low but measurable, so exposure (e) = 1. Sources: ECHA substance record, JECFA, PubChem/supplier pages, EWG listing.
- p-cresyl isovalerate est-il sûr pendant l'allaitement ?
- Same evidence base as pregnancy: no harmonised CMR classification or reproductive/developmental studies for this specific compound. Dermal exposure from cosmetic use is expected to be low but measurable (fragrance ester), so exposure = 1. No data showing secretion in milk or specific lactation effects.
- p-cresyl isovalerate est-il sûr pour la peau de bébé ?
- No infant‑specific toxicity or developmental studies found. Following instructions to increase exposure for infants when adult absorption is measurable, exposure is increased by +1 (adult e=1 → baby e=2) because infant skin has higher surface‑area‑to‑weight and immature barrier function. Hazard and mechanism remain 0 in absence of infant‑specific evidence.
- Comment VeriMom évalue-t-il p-cresyl isovalerate ?
- VeriMom évalue p-cresyl isovalerate à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à p-cresyl isovalerate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à p-cresyl isovalerate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.